EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation. - sprookjes - yvandenbroek - TriplyDB

EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

http://www.wikidata.org/entity/Q36319689

about

Insulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant disease Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2.Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes.Targeting of NHERF1 through RNA interference inhibits the proliferation and migration of metastatic prostate cancer cells SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells Regulation of ErbB2 localization and function in breast cancer cells by ERM proteins Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network.A novel NHE1-centered signaling cassette drives epidermal growth factor receptor-dependent pancreatic tumor metastasis and is a target for combination therapy.EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma.PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation.Clinical significance of EBP50 overexpression assessed by quantum dot analysis in gastric cancer.EBP50 suppresses the proliferation of MCF-7 human breast cancer cells via promoting Beclin-1/p62-mediated lysosomal degradation of c-Myc.NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings.Na+/H+ exchanger regulatory factor 1 overexpression suppresses the malignant phenotype of MIAPaCa-2 pancreatic adenocarcinoma cells by downregulating Akt phosphorylation.Regulation of β2-adrenergic receptor cell surface expression by interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL).NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression.

P2860

Q26800001-73D00FE3-46C0-420A-AC21-FA40AC7B149B Q33597837-DCEC57B2-8EA0-4ACD-ADA2-8666C473E8E4 Q33962655-A241835E-4963-484D-8EDA-BE6789264851 Q35128221-9DFFE4F9-559D-47B8-962E-B9FE4207ED12 Q36524074-750CA112-0FE4-460A-926C-322F09FA4531 Q36808215-A1CEAEDE-2FFD-46B1-8A01-936A68A2CA3F Q37295377-D21BDC5B-9CA7-42DC-BA6B-D68426254B7D Q37584289-E205B00F-231C-47F5-A8BC-064B12F1C6CE Q38505183-4210E5E8-3C93-4353-B9C6-5BF343B166FD Q38902585-75E5FD45-1882-4C3F-B3AD-FFD9656E3E13 Q38966467-98F6D0C3-E725-473D-B07D-819C07915B8A Q39076960-A88CE776-1737-47D1-9EBF-030B23777C06 Q42197616-375A6B53-B984-4D49-BB4D-DC52FD0195BF Q42654081-600D18BE-4739-49B8-B097-DA62F1A5F283 Q43106592-ED0F9FD2-1D9B-4172-BA41-691A48C4A4D3 Q47250144-DBE7C352-3137-4C65-B9A7-1178CE7E1971 Q49894086-212A24C4-5D0E-46A5-BF49-7074A34E6199 Q54112426-2C309AB9-264E-4E08-B4DB-597E7B139F03 Q55061344-A202E4F4-8948-4754-8981-B7A9E63EF1D1 Q55315464-39C2A8BE-2264-48BC-A43E-34F7E96E73BE

P2860

EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

http://www.wikidata.org/entity/Q36319689

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

EBP50 inhibits EGF-induced bre ...... blocking EGFR phosphorylation.

@ast

EBP50 inhibits EGF-induced bre ...... blocking EGFR phosphorylation.

@en

type

label

EBP50 inhibits EGF-induced bre ...... blocking EGFR phosphorylation.

@ast

EBP50 inhibits EGF-induced bre ...... blocking EGFR phosphorylation.

@en

prefLabel

EBP50 inhibits EGF-induced bre ...... blocking EGFR phosphorylation.

@ast

EBP50 inhibits EGF-induced bre ...... blocking EGFR phosphorylation.

@en

P1433

Q36319689-80D0B1B2-C082-4F5D-B2FC-650327AEFA7D

P1476

Q36319689-6FF52688-CB13-4292-AEB6-01D738039DF0

P2093

Q36319689-08A0DCD7-242E-4C2C-ADF5-1DDFE430D11C

Q36319689-1C71045F-B622-46D7-A358-4A81B9B24694

Q36319689-3E84C483-AEBD-44B0-8BD3-A99FDECA1F19

Q36319689-5BA4A4C5-54DB-458D-9606-835E7D24D622

Q36319689-887258C8-8030-4CD9-BB89-9FA529846199

Q36319689-8A9E68D8-3ED6-4C9A-8C7A-D4EB295EBAFC

Q36319689-8D93D7AF-3F1B-4AA9-8C75-E3B140467576

Q36319689-98E0C5F2-FAD4-4D77-B95F-C22BE53281AF

Q36319689-E15551D6-9987-48F6-B4C2-16BE4CB8B7F2

Q36319689-F2CF3120-C347-4471-815F-58C28E0E7E9E

P2860

Q36319689-011EC3AB-AD96-499B-94CE-C8E70A43D758

Q36319689-110B1522-4BAB-4558-A145-C83D503A24FD

Q36319689-1E226925-E9E7-4B0C-9C64-D5C8BB0DE640

Q36319689-1EA17E37-4F3C-455B-8379-AE3EF164DD33

Q36319689-2FA26D91-9D8F-4CD1-8DB4-1AC2A7420AA0

Q36319689-32A46A5D-50ED-4B59-91CF-920866E092FA

Q36319689-355FFC39-D702-47CB-BF2D-DE78421D2D79

Q36319689-429580B8-6819-4EF7-94DB-C4775980F0F4

Q36319689-4A5045DF-CB6B-4B67-8092-C33278E4668D

Q36319689-4AE3C678-7A37-4E1F-8406-F8F01FC748DD

P2888

Q36319689-361A7EBE-FF57-4095-BF41-8912F35ED815

P304

Q36319689-242C88AB-7024-422D-BD00-665DD811E4C7

P31

Q36319689-5AAC8D97-4B27-4329-8B08-A20942CEF5EA

P356

Q36319689-A27FDBF0-B8C4-4ADB-BC5F-AF62EFDE08D6

P433

Q36319689-570309CE-6212-4A8D-92BA-6F14DE367235

P478

Q36319689-EA86E919-7265-486F-B68F-4EC920618507

P577

Q36319689-6F5684AB-DE16-47B8-9D96-9895B6DA0436

P5875

Q36319689-CE81FA53-362F-4D7D-B4EA-4AD0CB555E75

P698

Q36319689-DE2979BF-5633-477A-A0BF-9949B9C6933D

P921

Q36319689-BC8DCF48-0CE3-45A1-928B-5BEA04086276

P932

Q36319689-7FDBBB83-0A1B-4DD2-AAC4-D0078306849A

P356

S00726-012-1277-Z

P1433

P1476

EBP50 inhibits EGF-induced bre ...... blocking EGFR phosphorylation.

@en

P2093

Duiping Feng

http://www.w3.org/2001/XMLSchema#string

Junfang Zheng

http://www.w3.org/2001/XMLSchema#string

Junqi He

http://www.w3.org/2001/XMLSchema#string

Longyan Yang

http://www.w3.org/2001/XMLSchema#string

Renyou Zhai

http://www.w3.org/2001/XMLSchema#string

Weihua Bian

http://www.w3.org/2001/XMLSchema#string

Wenfang Yao

http://www.w3.org/2001/XMLSchema#string

Yang Li

http://www.w3.org/2001/XMLSchema#string

Ying Xiong

http://www.w3.org/2001/XMLSchema#string

Zhiyu Yang

http://www.w3.org/2001/XMLSchema#string

P2860

EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling

PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.

Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases

ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation

Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?

EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma

Human Delta1-pyrroline-5-carboxylate synthase: function and regulation

Epidermal growth factor-related peptides and their receptors in human malignancies

Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc.

P2888

s00726-012-1277-z

P304

2027-2035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00726-012-1277-Z

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223958212

http://www.w3.org/2001/XMLSchema#string

P698

22476347

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

3472071

http://www.w3.org/2001/XMLSchema#string